Abstract:Introduction: Cannabis contains cannabidiol (CBD), the main non-psychoactive phytocannabinoid, but also many other phytocannabinoids that have therapeutic potential in the treatment of epilepsy. Indeed, the phytocannabinoids cannabigerolic acid (CBGA), cannabidivarinic acid (CBDVA), cannabichromenic acid (CBCA) and cannabichromene (CBC) have recently been shown to have anti-convulsant effects in a mouse model of Dravet syndrome (DS), an intractable form of epilepsy. Recent studies demonstrate that CBD inhibits voltage-gated sodium channel function, however, whether these other anti-convulsant phytocannabinoids affect these classic epilepsy drug-targets is unknown. Voltage-gated sodium (Na V ) channels play a pivotal role in initiation and propagation of the neuronal action potential and Na V 1.1, Na V 1.2, Na V 1.6 and Na V 1.7 are associated with the intractable epilepsies and pain conditions. Methods: In this study, using automated-planar patch-clamp technology, we assessed the profile of the phytocannabinoids CBGA, CBDVA, cannabigerol (CBG), CBCA and CBC against these human voltage-gated sodium channels subtypes expressed in mammalian cells and compared the effects to CBD. Results: CBD and CBGA inhibited peak current amplitude in the low micromolar range in a concentration-dependent manner, while CBG, CBCA and CBC revealed only modest inhibition for this subset of sodium channels. CBDVA inhibited Na V 1.6 peak currents in the low micromolar range in a concentration-dependent fashion, while only exhibiting modest inhibitory effects on Na V 1.1, Na V 1.2, and Na V 1.7 channels. CBD and CBGA non-selectively inhibited all channel subtypes examined, whereas CBDVA was selective for Na V 1.6. In addition, to better understand the mechanism of this inhibition, we examined the biophysical properties of these channels in the presence of each cannabinoid. CBD reduced Na V 1.1 and Na V 1.7 channel availability by modulating the voltage-dependence of steady-state fast inactivation (SSFI, V 0.5 inact), and for Na V 1.7 channel conductance was reduced. CBGA also reduced Na V 1.1 and Na V 1.7 channel availability by shifting the voltage-dependence of activation (V 0.5 act) to a more depolarized potential, and for Na V 1.7 SSFI was shifted to a more hyperpolarized potential. CBDVA reduced channel availability by modifying conductance, SSFI and recovery from SSFI for all four channels, except for Na V 1.2, where V 0.5 inact was unaffected. Discussion: Collectively, these data advance our understanding of the molecular actions of lesser studied phytocannabinoids on voltage-gated sodium channel proteins.

Cannabidiol Inhibits Nav Channels Through Two Distinct Binding Sites.

Cannabidiol Selectively Binds to the Voltage-Gated Sodium Channel Nav1.4 in Its Slow-Inactivated State and Inhibits Sodium Current

Inhibitory effects of cannabidiol on voltage-dependent sodium currents

Cannabinoid interactions with ion channels and receptors

Physiological profiling of cannabidiol reveals profound inhibition of sensory neurons

Beyond CBD: Inhibitory effects of lesser studied phytocannabinoids on human voltage-gated sodium channels

Cannabinoid inhibition of mechanosensitive K+ channels

Cannabidiol activates neuronal Kv7 channels

Endocannabinoid activation of the TRPV1 ion channel is distinct from activation by capsaicin

Cannabidiol inhibits multiple cardiac ion channels and shortens ventricular action potential duration in vitro

Functionally-selective inhibition of threshold sodium currents and excitability in dorsal root ganglion neurons by cannabinol

Cannabidiol and Sodium Channel Pharmacology: General Overview, Mechanism, and Clinical Implications

Structural basis for Na V 1.7 inhibition by pore blockers

Differential regulation of Cav 3.2 and Cav 2.2 calcium channels by CB1 receptors and cannabidiol

Inhibition of sodium conductance by cannabigerol contributes to a reduction of dorsal root ganglion neuron excitability

Use-Dependent Relief of Inhibition of Nav1.8 Channels by A-887826

Molecular mechanism of TRPV2 channel modulation by cannabidiol

Cannabidiol potentiates hyperpolarization-activated cyclic nucleotide–gated (HCN4) channels

Structural Mapping of Na V 1.7 Antagonists

Differential Inhibition of Nav1.7 and Neuropathic Pain by Hybridoma-Produced and Recombinant Monoclonal Antibodies That Target Nav1.7 : Differential Activities of Nav1.7-targeting Monoclonal Antibodies.

Cannabidiol inhibits febrile seizure by modulating AMPA receptor kinetics through its interaction with the N-terminal domain of GluA1/GluA2